Henry Meds Appears in 23.7% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
11 minutes read

Key Takeaways

  • Henry Meds is mentioned in about a quarter of benchmark answers, but it is recommended in fewer than one in ten.
  • The main issue is the gap between being mentioned and being endorsed, not overall reach alone.
  • Two medium-priority claim conflicts need verification before any page edits or correction requests are made.
  • The TRT treatment page is the highest-priority company page, and buyer-question content should focus on comparison and best-company queries.

Answer Capsule

In November 2026, Henry Meds appeared in 86 of 363 AI answers included in the TRT Clinics benchmark (23.69%). It received 35 recommendations (9.64%), with 28 Top 3 placements and 6 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do Henry Meds mentions, recommendations and placements compare with its TRT Clinics peers?

Henry Meds recorded 86 mentions (23.69%) and 35 recommendations (9.64%) across 363 answers included in the benchmark. Top 3 placements numbered 28; first-place recommendations numbered 6. Framing among its mentions was 36 positive, 39 neutral and 11 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

Hone Health

271

74.66%

146

40.22%

123

33.88%

64

17.63%

2

Defy Medical

113

31.13%

81

22.31%

64

17.63%

12

3.31%

3

Maximus

116

31.96%

64

17.63%

49

13.50%

18

4.96%

4

Marek Health

78

21.49%

39

10.74%

30

8.26%

7

1.93%

5

Henry Meds

86

23.69%

35

9.64%

28

7.71%

6

1.65%

6

Fountain TRT

57

15.70%

25

6.89%

13

3.58%

1

0.28%

7

Renew Vitality

6

1.65%

5

1.38%

5

1.38%

0

0.00%

8

Low T Center

11

3.03%

4

1.10%

2

0.55%

1

0.28%

9

BioTE

7

1.93%

0

0.00%

0

0.00%

0

0.00%

9

Craft Concierge

0

0.00%

0

0.00%

0

0.00%

0

0.00%

Henry Meds sits in the middle of the field: it appears in roughly a quarter of the answers and earns a recommendation in fewer than one in ten. Its mentions are more often neutral than positive, and negative framing is not trivial. That gap between being seen and being endorsed is the practical problem to work on.

The leaders are not just mentioned more often; they are endorsed far more often. Henry Meds is close to Marek Health on mentions but behind it on recommendations, which suggests the issue is not reach alone. The agency would treat endorsement share, not mention share, as the headline measure to improve.

Placement is thin relative to presence. Most of Henry Meds's recommendations do not land in the top three, and first-place finishes are rare. Because these are nested within recommendations, the useful reading is that the brand is in the conversation but seldom the answer's leading choice.

What changed since last month

Questions This Section Answers

  • How did Henry Meds counts and coverage differ across the available monthly snapshots?

Metric

Nov 2026

Mentions

86 / 363 (23.69%)

Recommendations

35 / 363 (9.64%)

Top 3 recommendations

28 / 363 (7.71%)

#1 recommendations

6 / 363 (1.65%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

This edition is the first broad baseline, so the monthly figures describe where Henry Meds stands now rather than a movement from earlier months. Earlier editions used a narrower question set, and the report does not treat their figures as a trend. Any comparison to them would be misleading.

The practical consequence is that the agency should not present this month as a gain or a decline. Instead, the baseline becomes the reference point against which later editions using the same screening scope can be read. The first job is to keep the measurement consistent so future months are genuinely comparable.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • Henry Medsno change
    Nov 20269.64%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for Henry Meds?

AI answers contained 2 conflicting claims about Henry Meds: 0 critical, 0 high, 2 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Two conflicting claims about Henry Meds appeared in the answers, both rated medium priority. Neither is critical or high, so they do not demand emergency action, but they do warrant a fact check before anything is published or corrected. The ratings prioritize review; they do not establish that anyone made an error.

The agency would build a visibility comparison that sets Henry Meds against the clinics above and below it, paired with a short list of claims to verify. That gives the client a clear sense of where the endorsement gap is widest and which disputed points are worth resolving first.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about Henry Meds should be verified before proposed page edits?

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

monthly starting price

medium

$179+/month

about $249/month

BBB accreditation/rating

medium

no accreditation, some older concerns (no F rating stated)

BBB F rating with 234 complaints

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

The disputed topics are the monthly starting price and the BBB accreditation and rating. Both columns quote AI answers, not verified company facts, and different dates or sources could explain an apparent conflict. The agency would resolve the entity, date and source before deciding whether any correction is warranted.

Page briefs would be prepared conditionally, using only facts the client confirms from current primary sources. Where the evidence does not settle a claim, the brief would note the open question rather than assert an answer. This keeps the website consistent without guessing which AI claim is true.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for Henry Meds?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://innerbody.com/henry-meds-reviews

25

16

2

https://peptidesexplorer.com/blog/henry-meds-reviews

11

10

2

https://trustpilot.com/review/henrymeds.com

8

7

2

https://forbes.com/health/weight-loss/henry-meds-review/

25

20

1

https://consumeraffairs.com/health/henry-meds.html

11

11

1

https://manytreatments.com/brands/henry-meds/reviews

7

7

1

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

Several cited pages carry more than one conflicting claim, and a few are cited often across captured answers. That makes them sensible starting points for source review, but a page linked to a conflict is not necessarily its cause, and its current contents still need checking. The agency would review each page before making any request.

Requests to publishers would be evidence-backed and specific, and the agency would not assume publisher control or error. Where a page is accurate, the outcome may be a no-change decision. The work is to separate genuine gaps from claims that simply reflect different dates or sources.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed Henry Meds website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://henrymeds.com/treatments/trt

27

27

20

https://henrymeds.com/

6

3

0

https://henrymeds.com/legal/programs

6

3

0

https://henrymeds.com/faq

4

3

0

https://henrymeds.com/treatments/erectile-dysfunction/icp

4

1

0

https://henrymeds.com/treatments/weight-management/semaglutide-oral

4

0

0

https://henrymeds.com/landing/weight-loss/a/q-p

3

1

0

https://henrymeds.com/landing/weight-management

3

2

0

The company's website was cited 88 times across 31 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The treatment page for TRT is by far the most cited company page and appears in many recommending answers, which makes it the natural first priority for a page brief. The homepage, legal and FAQ pages are cited far less and rarely alongside a recommendation. A cited page is not automatically one that accompanied an endorsement.

Briefs would use approved facts and the audience questions observed in the research, and the agency would check existing coverage before proposing anything new. The aim is to strengthen the pages that already carry weight rather than spread effort thinly across the site.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for Henry Meds?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What is the best online hormone replacement therapy?

2

2

2

trt online

2

2

2

trt treatment online

2

2

2

online trt therapy

2

2

1

How does Hone Health compare to other TRT clinics?

5

1

1

What is the best TRT company?

4

1

1

What is the best company to get TRT from?

4

1

1

What is the best online TRT company?

4

1

1

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions cluster around generic online TRT searches and best-company comparisons. Henry Meds appears in several of these but is recommended in only some, and the comparison question about a rival clinic is a clear example of a gap worth addressing. These are answer observations, not search volume or proof of missing content.

Content briefs would target the buyer questions where the brand is present but not endorsed, checking existing pages first. The agency would draft buyer-question content around what the answers actually ask, then let the client approve facts before publication.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed Henry Meds work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first month establishes the baseline scorecard, a scoped fact-review register and a shortlist of pages and sources. Each record needs an owner, an evidence requirement and a review status, so the client can see what is confirmed and what is still open.

The second month produces approved page briefs and justified publisher requests, with confirmed edits, no-change decisions, requests and responses recorded separately. The third month adds buyer-content briefs and a fresh scorecard. Completed work is reported apart from measured answer outcomes, and no visibility gain is promised.

Methodology

Questions This Section Answers

  • How are Henry Meds answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 363 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5316 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

363

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

The answers were collected on dates that have not been verified, and the rates rest on the answers that met the benchmark's inclusion rules. A company counts as recommended only when an answer endorses it with positive wording; top-three and first-place counts sit inside those recommendations rather than adding to them.

An answer can mention several companies, so company counts cannot be summed into distinct answers. The wider citation analysis covers more answers than the benchmark, and cited pages and disputed claims still need independent verification.

Our first three priorities

The first priority is to verify the two disputed claims against current primary sources, since both affect what buyers are told about price and accreditation. Until that is settled, no correction should be issued and no page brief should assert an answer.

The second is a page brief for the TRT treatment page, which carries most of the company's citation weight, using only approved facts and the buyer questions observed. The third is buyer-question content aimed at the comparison and best-company questions where Henry Meds appears but is not endorsed. Each is proposed work, and results will be reported separately from measured visibility.

This report supports CiteWorks Studio's examination of how AI search is recommending TRT Clinics. For more detail, you can also read TRT Clinics: AI Visibility Discovery Index.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT